Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.52

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.05

EPS Last/This Y

0.9

EPS This/Next Y

-0.43

Price

0.95

Target Price

8.67

Analyst Recom

1.25

Performance Q

-0.84

Relative Volume

0.59

Beta

1.8

Ticker: GOSS




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19GOSS0.84080.320.1141176
2024-12-20GOSS0.8280.320.0141166
2024-12-23GOSS0.85690.330.5339881
2024-12-24GOSS0.840.330.0839937
2024-12-26GOSS0.84310.330.0040076
2024-12-27GOSS0.82540.330.2740080
2024-12-30GOSS0.87550.330.0540107
2024-12-31GOSS0.90080.320.0940546
2025-01-02GOSS0.980.310.0242924
2025-01-03GOSS1.010.300.0944630
2025-01-06GOSS1.10.290.0244711
2025-01-07GOSS1.1050.300.0844780
2025-01-08GOSS1.0450.290.3345042
2025-01-09GOSS1.050.290.3345042
2025-01-10GOSS0.9720.300.0945216
2025-01-13GOSS0.92640.300.0545231
2025-01-14GOSS0.85760.290.0045323
2025-01-15GOSS0.92860.290.0145362
2025-01-16GOSS1.010.290.0345432
2025-01-17GOSS0.96220.290.0045485
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19GOSS0.8520.0-102.3-0.28
2024-12-20GOSS0.8420.0-78.1-0.28
2024-12-23GOSS0.8620.0-87.2-0.28
2024-12-24GOSS0.8420.0-72.7-0.28
2024-12-26GOSS0.8520.0-83.5-0.28
2024-12-27GOSS0.8420.0-74.6-0.28
2024-12-30GOSS0.8720.0-84.9-0.28
2024-12-31GOSS0.9020.0-88.7-0.28
2025-01-02GOSS0.9720.0-103.0-0.28
2025-01-03GOSS1.0220.0-94.1-0.28
2025-01-06GOSS1.1020.0-101.9-0.28
2025-01-07GOSS1.1120.0-81.9-0.28
2025-01-08GOSS1.0520.0-64.4-0.28
2025-01-09GOSS1.0520.0-78.2-0.28
2025-01-10GOSS0.9720.0-57.5-0.28
2025-01-13GOSS0.9320.0-65.8-0.28
2025-01-14GOSS0.8520.0-52.7-0.28
2025-01-15GOSS0.9220.0-113.0-0.28
2025-01-16GOSS1.0020.0-107.2-0.28
2025-01-17GOSS0.9520.0-64.5-0.28
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19GOSS0.95-4.633.66
2024-12-20GOSS0.95-4.633.66
2024-12-23GOSS0.71-4.633.66
2024-12-24GOSS0.71-4.633.66
2024-12-26GOSS0.00-4.634.03
2024-12-27GOSS0.00-4.634.03
2024-12-30GOSS0.00-4.694.03
2024-12-31GOSS0.00-4.694.03
2025-01-02GOSS0.00-4.694.03
2025-01-03GOSS0.00-4.694.03
2025-01-06GOSS0.00-4.694.03
2025-01-07GOSS0.00-4.694.03
2025-01-08GOSS0.00-4.694.03
2025-01-09GOSS0.00-4.694.03
2025-01-10GOSS0.00-4.694.03
2025-01-13GOSS0.00-4.693.52
2025-01-14GOSS0.00-4.693.52
2025-01-15GOSS0.00-4.693.52
2025-01-16GOSS0.00-4.693.52
2025-01-17GOSS0.00-4.693.52
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.14

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.19

Insider Transactions

Institutional Transactions

-4.69

Beta

1.8

Average Sales Estimate Current Quarter

6

Average Sales Estimate Next Quarter

3

Fair Value

Quality Score

22

Growth Score

18

Sentiment Score

14

Actual DrawDown %

94.3

Max Drawdown 5-Year %

-97

Target Price

8.67

P/E

Forward P/E

PEG

P/S

2.07

P/B

4.03

P/Free Cash Flow

EPS

-0.33

Average EPS Est. Cur. Y​

-0.28

EPS Next Y. (Est.)

-0.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-68.03

Relative Volume

0.59

Return on Equity vs Sector %

-151.4

Return on Equity vs Industry %

-138.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-64.5
Gossamer Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 135
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
stock quote shares GOSS – Gossamer Bio, Inc. Stock Price stock today
news today GOSS – Gossamer Bio, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GOSS – Gossamer Bio, Inc. yahoo finance google finance
stock history GOSS – Gossamer Bio, Inc. invest stock market
stock prices GOSS premarket after hours
ticker GOSS fair value insiders trading